Using Nanoparticles to Treat Cancer
Abstract
In this paper we briefly discuss methods of cancer treatment, such as
surgery, radiation therapy, and chemotherapy for further comparison, with
new cancer nanotechnology methods. The paper presents positive and
negative aspects of the use of nanoparticles for the cancer treatment . In
addition, this article describes a method for selecting a spectrum of
irradiation and nanoparticle size for therapy and diagnosis of oncological
diseases. Using computer calculations, the research demonstrates that
particle size at optimal radiation wavelength affects absorption and
scattering coefficients in low-absorbing biological media.

Introduction
Today, the main treatments for cancer are surgery, chemotherapy, and
radiation therapy. These therapies are chosen based on the type of
cancer, stage, and location. In many cases, doctors consider complex
therapies that include all these treatments concurrently. Although
technology is advancing from year to year, each of these methods has
several drawbacks, such as the inability to address certain types of
tumors, a difficult postoperative period when the tumor is large, high
toxicity, and damage to organs.
Most of the preparations in oncology are chemotherapy. These
medications are injected intravenously, spread through the body, and
poison the internal organs. Chemotherapy affects not only cancer cells,
but also healthy tissues, which is a serious problem. To solve this problem,
specialists decided to develop a new method of drug delivery by using
nanoparticles. (See Figure 1: The particles' size does not exceed 100
nanometers.) The specific feature of this delivery method is that
nanoparticles do not go beyond the healthy vessel walls; however, they
can penetrate tumor tissues through the damaged vessel walls
(Zvyagin, 2019).

One of the drawbacks of this method is the response of the
immune system, which quickly removes nanoparticles from the
bloodstream. Zvyagin (2019) states that one of the solutions to this
issue is to create hybrid nanoparticles that incorporate organic and
inorganic material and are able to avoid capture by the immune system
cells, therefore accumulating in the tumor and metastases.
In addition to chemotherapy, nanoparticles can be used in the
diagnosis and radiation therapy (Letfullin, R.R. George, T.F. 2016). When
nanoparticles are injected into the body, they accumulate in the
malignancy. To obtain accurate diagnoses, scientists make nanoparticles
visible through the contrast method in order to
locate them with the
diagnostic equipment CT, MRI, ultrasound. (Meshalkin, Bgatova, 2008).

Figure 2

Data analysis and results
Computer calculations of absorption coefficients Kabs and scattering
coefficients Ksca for silver nanoparticles in cytoplasm are shown in
Figure 4 and Figure 5. Figure 4 shows the absorption and scattering
spectra of silver particles in the range of λ=200-1000 nm, and Figure 5
shows the dependences of Kabs and Ksca on particle size for the
optimal wavelength. In Figures 4 and Figure 5 the maximum absorption
coefficient Kabs is marked at a wavelength of λ=389 nm and a silver
particle radius of 10 nm. For silver nanoparticles with a radius greater than
4.3 nm at λ=389 nm, the scattering of light can be recognized. The
scattering coefficient Ksca increases with the size of the nanoparticles and
becomes equal to the absorption coefficient at a particle radius of 17.1 nm.
When the particle size is equal to or greater than 17.1 nm, the scattering
coefficient becomes greater than the absorption coefficient.
Figure 4
Absorption and scattering spectrum

(Akramova R.B. 2022)
Here is an example of cancer therapy based on the use of
nanoparticles associated with the heating of metal nanoparticles by
infrared laser radiation (Meshalkin, Bgatova, 2008).
Figure 3

Note. Computer calculations of the absorption, Kabs and scattering, Ksca
coefficients for silver nanoparticles in a cytoplasm in range λ=200-100nm
For particles with a radius in the 1-17 nm range, the laser heating
efficiency is greater, since the absorption coefficient Kabs is much larger
than the scattering coefficient Ksca. Thus, a suitable size of silver
nanoparticles for cancer therapy by laser heating of nanoparticles at the
localization of cancer cells is 1-17 nm, where Kabs>1 and Kabs>Ksca. The
maximum effect of silver particles laser heating in cytoplasmic
environment is obtained for particles with a radius of 10 nm at a
wavelength of λ=389 nm (Kabs=17.77).

Figure 1

Figure 5
Absorption and scattering as a function of particle size

(Wei JuAn, 2014)

Method
Generally, gold or silver metals are used as bases for
nanoparticles. By entering the refractive index (Table 1) of the metal at
different wavelengths into a specialized program called "Mie Plot", we
select the wavelength at which the absorption coefficient of silver
nanoparticles is the highest at a given radius. Then by using this
wavelength, we determine the nanoparticle radius that will be most
suitable for diagnosis (scattering coefficient higher than the absorption
coefficient) and therapy (absorption coefficient higher than the
scattering coefficient) (Letfullin, R.R. George, T.F. 2016, p. 213-217).

(Akramova R.B., 2022)

Table 1
λ(nm)
400
(Cytoplasm)
500
600
700

Refractive
index,N
1.35

Kabs, max λmax, nm rmax,nm

1.36
1.365
1.367

17.77

389

10

Mie Theory Maximum Light-Absorption Factor (Kabs), Wavelength(λmax),
and Radius(rmax) for Silver in Media of Different Refractive Indexes.

Сonclusion
With the help of a detection system and re-radiation by
nanoparticles, it may be possible to diagnose cancer early, detect and
remove remaining malignant tissue after surgery. Nanoparticles can
also be used in cancer therapy, improving the accuracy of the
treatment.
Currently, specialists are facing multiple challenges that need to be
addressed in order to normalize the use of this method.
Almost no data is available on how nanoparticles will be
incorporated into biochemical processes in the human body, what is their
further pathway, the residence time in the human body, the place of
accumulation, the effects on cellular and tissue functions, their access to
blood circulation, and information on unintended reactions in vivo
(Zvyagin, 2019).
The disadvantages of nanoparticle experiments are costly and approvals
of medical authorities are complicated. However, nanotechnology
methods can be a good alternative for the classic use of chemotherapy
and radiotherapy, and an advanced diagnosis tool for oncology surgeries.
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